Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 2786 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 2809 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3190 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3250 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3693 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3755 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3766 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3816 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3851 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 3949 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4044 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4129 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4227 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4256 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4265 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4301 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4373 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4485 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4650 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4791 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 4844 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5165 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5297 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5431 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5483 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5508 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5528 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5604 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5677 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5699 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 5969 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6017 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6043 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6132 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6222 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6260 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6261 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6290 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6309 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6317 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6327 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6441 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6524 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6560 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6608 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6846 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 6959 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7035 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7037 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7138 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7148 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7197 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7281 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7286 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7296 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7331 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7361 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7379 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7400 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7426 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7616 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7740 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7827 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7882 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7893 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7960 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7967 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 7995 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8020 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8058 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8119 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8270 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8276 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8363 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8433 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8442 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8538 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8613 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 8797 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9046 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9281 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9481 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9553 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9630 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9852 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9870 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 9991 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10104 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10147 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10445 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10461 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10476 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10535 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10723 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 10730 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11034 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11375 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11450 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11621 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11690 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11781 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11821 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11865 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 11867 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12159 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12310 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12395 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12397 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12770 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12812 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 12813 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 13001 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 13011 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 13170 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 13188 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 13478 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 13843 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 14282 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 14305 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 14874 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 14987 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 15021 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 15128 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 15599 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 16189 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 16476 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 16960 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 17354 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 17654 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 18007 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 18700 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 19037 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 19058 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 19468 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 20090 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 20171 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 20888 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 20902 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 21175 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 21563 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 22321 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 23305 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 24351 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 24734 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 25038 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 25439 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 26436 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 27839 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 30083 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 30179 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 30221 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 30568 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 31875 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 32458 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 34372 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 35472 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 54150 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | LowRisk | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | No | PAH | Female | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | LowRisk | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | Yes | PAH | Female | Cath |